Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] ANTARCTIC: platelet function testing to adjust therapy

We carefully read the ANTARCTIC study by Guillaume Cayla and colleagues (Oct 22, p 2015),1 and would like to suggest a different interpretation of the results. The trial studied the utility of platelet function reactivity (assessed by VerifyNow) guidance in elderly patients (aged ≥75 years) with acute coronary syndrome and ST-elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention and were treated with prasugrel 5 mg daily. For power calculations, the investigators used a combined endpoint of ischaemic and bleeding events, and bleeding events drove the overall event rates.

email